智通财经APP获悉，在神经分泌生物科学 (NBIX.US)公布了未达预期的 DCP 三期研究结果后，德银重申其“持有”评级，并维持152美元目标价。该行认为，投资者对此次临床结果的预期较低，预计股价受到的影响将微乎其微。

DCP Midstream earned the ire of investors last year when it slashed its distribution, even though it did not actually need to. The company enjoys reasonably stable cash flows that are not affected too ...

Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends? Fortunately for investors ...

DCP Midstream, LP DCP is set to report fourth-quarter 2020 results on Feb 10, after the closing bell. In the last reported quarter, the partnership generated earnings of 46 cents per unit, which beat ...

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks ...

In this article we will check out the progression of hedge fund sentiment towards DCP Midstream LP (NYSE:DCP) and determine whether it is a good investment right now. We at Insider Monkey like to ...

PSX announced an agreement Friday to buy the remaining publicly held LP units in DCP Midstream for $41.75 each, raising Phillips 66's stake in DCP to 86.8%. The remaining economic interests in DCP are ...

DCP Midstream (DCP +0.00%) is a significant player in the North American midstream industry, but units of the MLP have been trading all over the place. At its worst, DCP was down more than 90% in 2020 ...

First scenario: You go to the multiplex. The words “Presented in Sony 4K” sweep across the screen in pixie dust, but as the previews begin, there’s no sound. So you call out to the projection booth, ...